Hangzhou Medical Biotechnology

Hangzhou Medical Biotechnology is a Chinese biopharmaceutical company focused on the research, development, and commercialization of innovative biological drugs and high-end generic medicines. The company specializes in therapeutic areas such as autoimmune diseases, oncology, and infectious diseases, with a strong emphasis on recombinant protein technology and small molecule inhibitors. Hangzhou Medical Biotechnology operates integrated R&D and manufacturing facilities that comply with international GMP standards. Their portfolio includes several marketed products in the Chinese domestic market, alongside a growing pipeline of biosimilars and novel chemical entities. The company aims to provide affordable, high-quality medical solutions to patients globally through strategic partnerships and continuous technological innovation.